ABRYSVO®
Consumer Medicine Information (CMI) summary
The full CMI on the next page has more details. If you are worried about using this medicine,
speak to your doctor or pharmacist.
This vaccine is new or being used differently. Please report side effects. See the
full CMI for further details.
ABRYSVO is a vaccine given to prevent disease of the respiratory tract (airways and
lungs) caused by a virus called respiratory syncytial virus (RSV). ABRYSVO is given
to pregnant individuals to protect their infants from birth through 6 months of age,
or individuals 60 years of age or older.
ABRYSVO contains the active ingredient recombinant respiratory syncytial virus pre-fusion
F protein.
For more information, see Section 1. Why am I being given ABRYSVO? in the full CMI.
You should not be given ABRYSVO if you have ever had an allergic reaction to ABRYSVO
or any of the ingredients listed at the end of the CMI. Tell your healthcare professional
if you have or have had an allergic reaction after being given any other vaccine in
the past, bleeding problems, have an infection with a high fever, anxiety or fainting
following any needle injections or a weakened immune system.
Talk to your doctor if you have any other medical conditions, take any other medicines,
or are pregnant or plan to become pregnant or are breastfeeding.
For more information, see Section 2. What should I know before I am given ABRYSVO? in the full CMI.
Tell your healthcare professional if you are taking any other medicines, including
any medicines, vitamins or supplements that you buy without a prescription from your
pharmacy, supermarket or health food shop.
Tell your healthcare professional if you have recently been given or plan to be given
any other vaccine.
For more information, see Section 3. What if I am taking other medicines? in the full CMI.
ABRYSVO will be given as a single dose injection into the muscle of your upper arm
by a doctor, nurse or other trained healthcare professional.
More instructions can be found in Section 4. How is ABRYSVO given? in the full CMI.
Things you should do
|
Check with your healthcare professional before you receive any other vaccines or take
other medicines.
|
---|---|
Driving or using machines
|
ABRYSVO is unlikely to affect your ability to drive or use machines.
|
Looking after your medicine
|
ABRYSVO will normally be stored at the doctor's surgery or in the pharmacy.
If you need to store ABRYSVO, store the carton in a refrigerator (2°C to 8°C) in the
original package.
Do not freeze. Discard if the carton has been frozen.
|
For more information, see Section 5. What should I know after being given ABRYSVO? in the full CMI.
Side effects of ABRYSVO include: pain, swelling or redness in the area where the vaccine
was given, muscle pain and headaches. Serious side effects include allergic reactions.
For more information, including what to do if you have any side effects, see Section
6. Are there any side effects? in the full CMI.
This vaccine is subject to additional monitoring. This will allow quick identification
of new safety information. You can help by reporting any side effects you may get.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems .
ABRYSVO®
Active ingredient(s):
recombinant respiratory syncytial virus pre-fusion F protein
Consumer Medicine Information (CMI)
This leaflet provides important information about using ABRYSVO. You should also speak to your healthcare professional if you would like further information
or if you have any concerns or questions about using ABRYSVO.
Where to find information in this leaflet:
ABRYSVO is a vaccine, which is a type of medicine that helps to protect (immunise)
people from certain infectious diseases. It does this by preparing the body's defences
to fight the infection before you catch the bacteria or virus.
ABRYSVO is used to prevent disease of the respiratory tract (lungs) caused by a virus
called respiratory syncytial virus (RSV).
ABRYSVO contains a protein (antigen) from each of the two subgroups (A and B) of RSV.
RSV is a common virus which, in most cases, causes mild, cold-like symptoms such as
a sore throat, cough or a blocked nose. However, some individuals are at higher risk
of respiratory disease caused by RSV. This includes young infants, older adults and
those with chronic medical conditions such as heart or lung disease. In infants RSV
can cause serious lung problems such as bronchiolitis and pneumonia. In older adults
it can make existing conditions such as chronic obstructive pulmonary disease (COPD)
and congestive heart failure (CHF) worse. It can lead to hospitalisation in severe
cases, and in some cases it can be fatal.
ABRYSVO is given to:
pregnant individuals to protect their infants from birth through 6 months of age,
or
individuals 60 years of age or older.
As with any vaccine, ABRYSVO may not fully protect all those who receive it.
Do not use ABRYSVO if:
you are allergic to ABRYSVO or any of the ingredients listed at the end of this leaflet
Check with your doctor if you:
have any other medical conditions
take any medicines for any other condition
have an infection with a high fever
If this is the case, then vaccination will be postponed. There is no need to delay
vaccination for a minor infection, such as a cold, but talk to your doctor first.
have any bleeding problems or disorders, or bruise easily
are feeling nervous about the vaccination process or have ever fainted following any
needle injection
have a weakened immune system which may prevent you from getting the full benefit
from ABRYSVO
are less than 24 weeks pregnant
are less than 18 years of age
During vaccination, you may be at risk of developing certain side effects. It is important
you understand these risks and how to monitor for them. See additional information
under Section 6. Are there any side effects?
Pregnancy and breastfeeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to
have a baby, ask your doctor or pharmacist for advice before you receive this vaccine.
Pregnant individuals can be given this vaccine in the late second or third trimester
(weeks 24 to 36).
It is unknown whether ABRYSVO is excreted into breast milk.
Tell your doctor or pharmacist if you are taking any other medicines, including any
medicines, vitamins or supplements that you buy without a prescription from your pharmacy,
supermarket or health food shop.
Tell your healthcare professional if you have recently been given or plan to be given
any other vaccine.
How many injections will be given
For the vaccination of pregnant individuals to protect their infants
One single dose is given in the late second or third trimester of pregnancy (24 -
36 weeks).
For the vaccination of adults aged 60 years or over
One single dose is given.
Multiple vaccinations
If ABRYSVO is given at the same time as another vaccine, a different injection site
will be used for each injection.
If you are given too much ABRYSVO
Overdose is unlikely as ABRYSVO is available in a single dose presentation and will
be given by a trained healthcare professional.
Things you should do
Check with your healthcare professional before you receive any other vaccines or take
other medicines.
Looking after your medicine
ABRYSVO will normally be stored at the doctor's surgery or in the pharmacy.
If you need to store ABRYSVO, store the carton in a refrigerator (2°C to 8°C) in the
original package.
Do not freeze. Discard if the carton has been frozen.
Follow the instructions in the carton on how to take care of your medicine properly.
Keep it where young children cannot reach it.
Getting rid of any unwanted medicine
Your healthcare professional will dispose of any unused vaccine.
All medicines can have side effects. If you do experience any side effects, most of
them are minor and temporary. However, some side effects may need medical attention.
See the information below and, if you need to, ask your healthcare professional if
you have any further questions about side effects.
Side effects
Side effects
|
What to do
|
---|---|
Injection site reactions:
Pain, redness or swelling around the area where the injection was given.
Effects on the body:
Muscle pain
Headaches
Mild tingling in the toes or fingers that doesn't seem to spread or get worse.
|
Speak to your doctor if you have any of these side effects and they worry you.
|
Allergic reactions:
Allergic reaction such as rash, itching or hives on the skin, swelling of the face,
lips, tongue or other parts of the body, shortness of breath or trouble breathing
Effects on the body:
Tingling or weakness, usually starting in the legs then spreading up your body
Difficulty walking or climbing stairs
Difficulty with facial movements, including speaking, chewing or swallowing; choking
on saliva
Double vision or inability to move the eyes
Severe pain that may feel like aches, shooting pain or cramps that may be worse at
night
Difficulty breathing or shortness of breath when lying flat
Effects on the heart:
Rapid heart rate
Low or high blood pressure
|
Call your doctor straight away, or go straight to the Emergency Department at your
nearest hospital if you notice any of these serious side effects.
|
Tell your healthcare professional
if you notice anything else that may be making you feel unwell.
Other side effects not listed here may occur in some people.
Reporting side effects
After you have received medical advice for any side effects you experience, you can
report side effects to the Therapeutic Goods Administration online at www.tga.gov.au/reporting-problems . By reporting side effects, you can help provide more information on the safety of
this medicine.
This medicine is only available with a doctor's prescription.
What ABRYSVO contains
Active ingredients
(main ingredients)
|
Powder:
RSV subgroup A stabilised pre-fusion F protein
RSV subgroup B stabilised pre-fusion F protein
|
---|---|
Other ingredients
(inactive ingredients)
|
Powder:
trometamol
trometamol hydrochloride
sucrose
mannitol
polysorbate 80
sodium chloride
Diluent:
water for injections
|
Potential allergens
|
n/a
|
Do not use this medicine if you are allergic to any of these ingredients.
ABRYSVO does not contain lactose, gluten, tartrazine or any other azo dyes.
What ABRYSVO looks like
ABRYSVO is supplied as:
a white powder in a glass vial, plus
a diluent in a pre-filled syringe to dissolve the powder
After dissolving the powder in the diluent, the solution is clear and colourless.
ABRYSVO is supplied in cartons containing:
1 vial of powder for injection, 1 pre-filled syringe of diluent and 1 vial adapter
10 vials of powder for injection, 10 pre-filled syringes of diluent and 10 vial adapters
(AUST R 406624)